Cronos logo
Cronos
CRON | NASDAQ
Chart Builder DCF Calculator
$3.27
-$0.11 (-3.25%)
At close: Nov 16, 2026, 4:00 PM ET
$3.29
+$0.02 (+0.61%)
After-hours: Nov 16, 2026, 7:50 PM ET

Cronos Company Profile

Company profile explained

Company Profile

Cronos Group Inc. is a company primarily focused on cannabinoids. In the United States, it develops, promotes, and supplies hemp-derived wellness and beauty products under the Lord Jones and Happy Dance brands, reaching consumers through online sales, traditional retail outlets, and partnerships within the hospitality sector. Beyond hemp, the company also engages in the cultivation, production, and commercialization of cannabis and its related extracts for both therapeutic and recreational consumption. Its cannabis offerings encompass dried flower, pre-rolled joints, edibles, concentrates, and various extracts, which are distributed via wholesale channels and directly to clients. The wellness segment operates under the PEACE NATURALS platform, while its adult-use products are marketed through the Spinach brand. Additionally, Cronos exports dried cannabis and cannabis oils to international markets such as Germany, Israel, and Australia. Founded in 2012, the company's headquarters are located in Toronto, Canada.

Key Executives

Name Position
Michael Ryan Gorenstein President, Chief Executive Officer & Chairman
Anna Shlimak Chief Financial Officer
Adam Wagner General Manager of Cronos Israel
Arye Weigensberg Senior Vice President and Head of Research & Development
Harrison Aaron Senior Director of Investor Relations & Corporate Development
Jared Matthew Kenost Principal Accounting Officer, Vice President & Controller
Jeffrey David Jacobson Chief Growth Officer
Shannon Buggy Senior Vice President & Global Head of People
Terry Gregory-Joseph Doucet General Counsel & Corporate Secretary

Latest SEC Filings

Date Type Title
Oct 20, 2026 4 Filing
Oct 20, 2026 3 Filing
Oct 15, 2026 8-K Current Report
Sep 11, 2026 8-K Current Report
Aug 07, 2026 4 Filing
Aug 07, 2026 4 Filing
Aug 07, 2026 4 Filing
Aug 07, 2026 8-K/A [Amend] Current Report
Aug 06, 2026 10-Q Quarterly Report
Aug 06, 2026 8-K Current Report
View All SEC Filings ➞
Cronos
Cronos logo
Country Canada
IPO Date Feb 27, 2018
Industry Drug Manufacturers - Specialty & Generic
Sector Healthcare
Employees 610
CEO Michael Ryan Gorenstein

Contact Details

4491 Concession Road 12 Stayner, ON L0M 1S0 Canada

Stock Details

Ticker Symbol CRON
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001656472
CUSIP Number 22717L101
ISIN Number CA22717L1013
SIC Code 2833

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.